APH

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) (the "Company" or
"ALDA") announces that a joint venture agreement has been established with
Seavan Health & Beauty Partnership ("Seavan"). Under the terms of the agreement,
Seavan will manufacture ALDA's products and ALDA's personnel will undertake the
marketing and sales of Seavan's products and services in addition to those of
ALDA. The acquisition of substantially all of the assets and undertakings of
Seavan by ALDA is still in progress.


Dr. Terrance Owen, President & CEO, states, "During our discussions with Seavan,
it became clear that it would be beneficial for us to work together now because
the two companies are very complimentary and can benefit from each other's
strengths. This joint venture will allow us to combine our resources, fine-tune
our delivery of both ALDA's and Seavan's products and services and grow both
businesses as we work on the acquisition. The ultimate goals are for ALDA to
manufacture as well as distribute T36(R) products, acquire expertise in R&D,
quality assurance and regulatory matters and re-focus on the therapeutic
applications of the T36(R) technology."


About Seavan Health & Beauty Partnership (www.seavanlabs.com)

Seavan, located in Vancouver, manufactures pharmaceutical, nutritional and
personal care products under licenses from Health Canada and the FDA. Examples
of products manufactured at Seavan include glucosamine and magnesium
supplements, sun screens, topical delivery systems, pain relievers, body washes,
hair care products and ALDA's T36(R) products.


About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived
from its patented T36(R) technology. The company trades on the TSX Venture
Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The
Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and
the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the
Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian
Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant
cleaning products. The Company was also selected as one of the TSX Venture 50
companies in the Technology and Life Sciences sector for 2010.


Terrance G. Owen, Ph.D., MBA, President & CEO 

ALDA Pharmaceuticals Corp.

Cautionary Note Regarding Forward-looking Statements: Information in this press
release that involves ALDA's expectations, plans, intentions or strategies
regarding the future are forward-looking statements that are not facts and
involve a number of risks and uncertainties. ALDA generally uses words such as
"outlook", "will", "could", "would", "might", "remains", "to be", "plans",
"believes", "may", "expects", "intends", "anticipates", "estimate", "future",
"plan", "positioned", "potential", "project", "remain", "scheduled", "set to",
"subject to", "upcoming", and similar expressions to help identify
forward-looking statements. The forward-looking statements in this release are
based upon information available to ALDA as of the date of this release, and
ALDA assumes no obligation to update any such forward-looking statements.
Forward-looking statements believed to be true when made may ultimately prove to
be incorrect. These statements are not guarantees of the future performance of
ALDA and are subject to risks, uncertainties and other factors, some of which
are beyond its control and may cause actual results to differ materially from
current expectations.

Aphria Inc. (TSXV:APH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Aphria Inc. (TSXV:APH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024